(1) Cui, B., Chen, Y., Luo, F., Lin, S., Liu, H., Huang, Y., Zhou, Y., Tian, Y., Yin, G., & Xie, Q. (2022). Clinical value of YKL-40 in patients with polymyositis/dermatomyositis: A cross-sectional study and a systematic review. Journal of Clinical Laboratory Analysis, 36(9), 1-8.
(2) Cui, B., Tian, Y., Ma, X., Yin, G., & Xie, Q. (2021). Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies. Frontiers in Immunology, 12(0).
(3) Cui, B., Pu, H., Liu, J., He, W., Zhou, Y., Zhou, X., Lin, H., & Peng, L. (2022). The effect of community-acquired pneumonia on myocardial injury in systemic lupus erythematosus: Insights from cardiac magnetic resonance. Lupus, 31(10), 1263-1268.
(4) Cui, B., Chen, Y., Tian, Y., Liu, H., Huang, Y., Yin, G., & Xie, Q. (2022). Effects of medications on incidence and risk of knee and hip joint replacement in patients with osteoarthritis: A systematic review and meta-analysis. Advances in Rheumatology, 62(1), 1-11.
Early bird registration is open and closes May 2025. Register now
